Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Biochem Pharmacol. 2020 Mar 26;177:113934. doi: 10.1016/j.bcp.2020.113934

Fig. 3.

Fig. 3.

Transiently transfected cells (A) are compared with the newly developed stable cell system (B), each expressing the A3AR-LgBiT and SmBiT-miniGαi constructs. The left panel shows the corrected activation profiles obtained by testing a concentration range (evaluated in duplicate) of the A3AR agonist 2-Cl-IB-MECA, the right panel shows the corresponding sigmoidal concentration–response curve. Data of one representative experiment are shown.